Peptide record

TPDB03832

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
25 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03832
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia AntiCP 2.0 iACP-DRLF Antifungipept CAFPdb ToxinPred 3.0
standard
No
A 25-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GIGAAILSAGKSALKGLAKGLAEHF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C108H182N30O30
RNDCQMPTWYV
A
2380.82
10.32
4
1
13
+2
-0.53
0.632
117.60
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
2
Residue Composition
number
6
A
0
R
0
N
0
D
0
C
1
E
0
Q
5
G
1
H
2
I
4
L
3
K
0
M
1
F
0
P
2
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 6 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 5 H: 1 I: 2 L: 4 K: 3 M: 0 F: 1 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
25 reviewed residue count
C108H182N30O30 sequence-only estimate (linear, free termini)
2380.82 sequence-only estimate (linear, free termini)
10.32 sequence-only estimate (linear, free termini)
+2 sequence-only estimate (linear, free termini)
-0.53 sequence-only estimate (linear, free termini)
0.632 sequence-only estimate (linear, free termini)
Evidence Records 5 records
Evidence 1 Activity

Activity

Antibacterial

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against N. meningitidis strains 118V, 15240, 126E, N. gonorrhoeae, N. lactamica, and N. cinerea (59-100% at 20 ug/ml), but did not kill E.coli, K.acyloca, P.aeruginosa, K.pmeumoniae, E.cloacae under the same conditions. Also active against B. megaterium BmII, S. aureus Cowan1, E. coli D21, E. coli D22, Y. pseudotubercolosis, P. aeruginosa ATCC 15692, and C. albicans ( Simmaco et al. 1998 ).
Evidence 2 Activity

Activity

Antifungal

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against N. meningitidis strains 118V, 15240, 126E, N. gonorrhoeae, N. lactamica, and N. cinerea (59-100% at 20 ug/ml), but did not kill E.coli, K.acyloca, P.aeruginosa, K.pmeumoniae, E.cloacae under the same conditions. Also active against B. megaterium BmII, S. aureus Cowan1, E. coli D21, E. coli D22, Y. pseudotubercolosis, P. aeruginosa ATCC 15692, and C. albicans ( Simmaco et al. 1998 ).
Evidence 3 Activity

Activity

Antiparasitic

Source & Reference

DRAMP

Other

Active against N. meningitidis strains 118V, 15240, 126E, N. gonorrhoeae, N. lactamica, and N. cinerea (59-100% at 20 ug/ml), but did not kill E.coli, K.acyloca, P.aeruginosa, K.pmeumoniae, E.cloacae under the same conditions. Also active against B. megaterium BmII, S. aureus Cowan1, E. coli D21, E. coli D22, Y. pseudotubercolosis, P. aeruginosa ATCC 15692, and C. albicans ( Simmaco et al. 1998 ).
Evidence 4 Activity

Activity

Toxicity
Hemolytic Cytotoxic
- | NA | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Bombinin-like peptides with antimicrobial activity from skin secretions of the Asian toad, Bombina orientalis. | J Biol Chem | 1991
Evidence 5 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref:1744108] No significant hemolytic activity was found which suggests a selectivity for prokaryotic over eukaryotic membranes.

Target

erythrocytes

Source & Reference

NA
DRAMP
J Biol Chem. 1991 Dec 5 266(34):23103-23111.